XML 31 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows
$ in Millions
9 Months Ended
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
OPERATING ACTIVITIES:    
Net income $ 461 $ 481
Adjustments to net income:    
Depreciation and amortization 836 800
Gain (loss) on disposal and sale of business interests 4 0
Impairment expense 358 533
Deferred income taxes (102) 0
Loss of affiliates, net of dividends 47 78
Emissions Allowance Expense 211 319
Loss on realized/unrealized foreign currency 184 45
Other 150 (1)
Changes in operating assets and liabilities:    
(Increase) decrease in accounts receivable 16 (409)
(Increase) decrease in inventory 253 (361)
(Increase) decrease in prepaid expenses and other current assets 76 (116)
(Increase) decrease in other assets (4) 251
Increase (decrease) in accounts payable and other current liabilities (187) 108
Increase (decrease) in income tax payables, net and other tax payables (67) (131)
Increase (decrease) in deferred income 50 48
Increase (decrease) in other liabilities 23 4
Net cash provided by operating activities 2,309 1,649
INVESTING ACTIVITIES:    
Capital expenditures (5,295) (2,711)
Payments to Acquire Businesses and Interest in Affiliates 311 114
Proceeds from Divestiture of Businesses and Interests in Affiliates 98 1
Sale of short-term investments 1,002 654
Purchase of short-term investments (764) (1,091)
Contributions and loans to equity affiliates (147) (202)
Proceeds from Collection of Advance to Affiliate 0 71
Payments to Acquire Intangible Assets (161) (415)
Other investing (95) (18)
Net cash used in investing activities (5,673) (3,825)
FINANCING ACTIVITIES:    
Borrowings under the revolving credit facilities and commercial paper program 33,981 4,214
Repayments under the revolving credit facilities and commercial paper program (32,168) (2,782)
Issuance of recourse debt 1,400 200
Repayments of recourse debt 0 (29)
Issuance of non-recourse debt 1,784 3,554
Repayments of non-recourse debt (1,262) (1,772)
Payments for financing fees (76) (83)
Purchases under supplier financing arrangements (1,307) (299)
Repayments of obligations under supplier financing arrangements 1,099 234
Distributions to noncontrolling interests (173) (129)
Acquisitions of noncontrolling interests (12) (541)
Contributions from noncontrolling interests 63 122
Sales to Noncontrolling Interests 371 336
Issuance of Preferred Shares in Subsidiaries 3 60
Dividends paid on AES common stock (333) (316)
Payments for financed capital expenditures (8) (23)
Other financing (38) (13)
Net cash provided by financing activities 3,740 2,863
Effect of exchange rate changes on cash, cash equivalents and restricted cash (108) (44)
Net Cash Change Of Discontinued And Held For Sale Businesses (20) (93)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 248 550
Cash, cash equivalents and restricted cash, beginning 2,087 1,484
Cash, cash equivalents and restricted cash, ending 2,335 2,034
SUPPLEMENTAL DISCLOSURES:    
Cash payments for interest, net of amounts capitalized 735 654
Cash payments for income taxes, net of refunds 267 203
SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES:    
Noncash or Part Noncash Divestiture, Amount of Consideration Received 215 15
Lease Obligation Incurred 187 129
Non-cash contributions from noncontrolling interests 60 $ 0
Other current assets $ 1,472